| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 16 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 3 | FUROSEMIDE | 13 |
| 4 | FILGRASTIM | 9 |
| 5 | FLUDARABINE PHOSPHATE | 9 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 9 |
| 7 | ALLOPURINOL | 8 |
| 8 | DOXORUBICIN | 8 |
| 9 | PANTOPRAZOLE SODIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 3 | 0.0012 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 2 | PENTOSTATIN | 1 | 0.0010 |
| 3 | MARIBAVIR | 2 | 0.0008 |
| 4 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 3 | 0.0007 |
| 5 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 6 | PLERIXAFOR | 1 | 0.0007 |
| 7 | LETERMOVIR | 2 | 0.0006 |
| 8 | POLATUZUMAB VEDOTIN | 6 | 0.0006 |
| 9 | AMIKACIN SULFATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Alkylating Drug [EPC] | 21 |
| 2 | Loop Diuretic [EPC] | 13 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 4 | Glycopeptide Antibacterial [EPC] | 9 |
| 5 | Leukocyte Growth Factor [EPC] | 9 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 9 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 8 | Benzodiazepine [EPC] | 7 |
| 9 | Opioid Agonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 4 | Oxazolidinone Antibacterial [EPC] | 5 | 0.0002 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 6 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 7 | Glycopeptide Antibacterial [EPC] | 9 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |